Catalyst

Slingshot members are tracking this event:

Pfizer (PFE) Terminates Development of Cholesterol Lowering Candidate Bococizumab

Source Link:
http://www.pfizer.com/news/press-release/press-release-detail/pfizer_discontinues_global_development_of_bococizumab_its_investigational_pcsk9_inhibitor

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PFE
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Nov 01, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Development, Termination, Cholesterol Lowering, Bococizumab
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.